Related Experiment Videos
Tyrosine kinase expression profile in bladder cancer
1Department of Medical Technology, China Junior College of Medical Technology, Tainan, Taiwan, R.O.C.
Anticancer Research
|July 1, 1997
Summary
Tyrosine kinase expression in bladder cancer was studied. TRK-E and Arg kinases were highly expressed, and a novel kinase clone was identified.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Bladder cancer is a significant health concern.
- Understanding the molecular mechanisms, including kinase expression, is crucial for developing targeted therapies.
- Tyrosine kinases play vital roles in cellular signaling pathways implicated in cancer development.
Purpose of the Study:
- To investigate the expression patterns of tyrosine kinases in bladder cancer cells.
- To identify specific kinases that are differentially expressed in bladder tumors.
- To discover novel kinase-related sequences in bladder cancer.
Main Methods:
- Polymerase Chain Reaction (PCR) amplification was employed.
- Degenerate primers targeting conserved catalytic domains of tyrosine kinases were utilized.
- Sequence analysis was performed to identify known and novel genes.
Main Results:
- TRK-E and Arg kinases showed higher expression levels compared to other kinases in bladder cancer samples.
- A novel DNA sequence (clone) was identified that did not match existing GeneBank entries.
- Sequence similarity analysis suggested this novel clone may encode a serine/threonine kinase.
Conclusions:
- Specific tyrosine kinases, namely TRK-E and Arg, are significantly expressed in bladder cancer.
- The identification of a novel kinase-related sequence opens avenues for further research into its function and potential role in bladder cancer.
- Further characterization of the novel serine/threonine kinase is warranted to understand its implications in bladder cancer pathogenesis.